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1
CYTOCHROME P450s AND USES THEREOF

2
1-hydroxylase, responsible for hydroxylating 1-deoxycap

CROSS REFERENCE TO RELATED
APPLICATIONS

Hoshino et al. (Phytochemistry 38:609-613, 1995) added to
the observations of Whitehead et al. (Phytochemistry 28:775

sidiol at the C1 to generate capsidiol, Was constitutive.

779, 1989) by directly measuring 3-hydroxylase-activity in
This application claims bene?t of US. provisional appli

microsomal preparations of arachidonic acid-elicited Capsi

cation Ser. Nos. 60/274,421 and 60/275,597, ?led on Mar. 9,
2001 and Mar. 13, 2001, respectively, both of Which are

cum annuum fruits and seedlings. These assays consisted of

hereby incorporated by reference.

and subsequently determining the amount of 1-deoxycapsid
iol generated by a combination of thin-layer chromatography
(TLC) separations and gas chromatography (GC). Their evi

incubating 5-epi-aristolochene With microsome preparations

FIELD OF THE INVENTION

dence demonstrated that the conversion of 5-epi-aris
This invention relates to cytochrome P450s and uses
thereof.

tolochene to 1-deoxycapsidiol Was dependent on both

NADPH and O2, and that 1-deoxycapsidiol accumulation in
vitro Was arrested by the P450 antagonists carbon monoxide

BACKGROUND OF THE INVENTION

(Omura and Sato, J. Biol. Chem. 239:2370-2378, 1964),
ancymidol (Coolbaugh et al., Plant Physiol. 62:571-576,

Cytochrome P450s encompass a superfamily of oxidases
responsible for the oxidation of numerous endobiotics and

thousands of xenobiotics. In addition, in plants, cytochrome
P450s play important roles in Wound healing, pest resistance,
signaling, and anti-microbial and anti-fungal activity.
Capsidiol is a bicyclic, dihydroxylated sesquiterpene pro
duced by many Solanaceous species in response to a variety
of environmental stimuli, including exposure to UV (Back et

1978), and ketoconaZole (Rademacher, Annu. Rev. Plant
20

synthesis. In studies to evaluate the effectiveness of methyl
jasmonate as an inducer of capsidiol biosynthesis in tobacco
25

al., Plant Cell. Physiol. 389:899-904, 1998) and infection by
microorganisms (Molot et al., Physiol. Plant Pathol. 379-389,
1981; Stolle et al., Phytopathology 78:1193-1197, 1988;

sesquiterpene cyclase reaction Were limiting. Using an in vivo
assay measuring the conversion rate of radiolabeled 5-epi
30

fungal elicitation, and it is derived from the isoprenoid path
Way via its hydrocarbon precursor, 5-epi-aristolochene (FIG.
1). Several of the biosynthetic enZymes leading up to 5-epi
aristolochene formation have been studied (Chappell, Annu.
Rev. Plant Physiol. Plant Mol. Biol. 46:521-547, 1995), espe

cell cultures, Mandujano-ChaveZ et al. (Arch. Biochem. Bio
phys. 381 :285-294, 2000), reported that the modest accumu
lation of this phytoalexin Was accompanied by a strong induc
tion of EAS. This result implied that steps before or after the

Keller et al., Planta. 205:467-476, 1998). It is the primary
antibiotic or phytoalexin produced in tobacco in response to

Physiol. Plant Mol. Biol. 51:501-531, 2000).
Recent results suggest that the hydroxylation of 5-epi
aristolochene is an important regulated step in capsidiol bio

aristolochene to capsidiol, a very limited induction of the
hydroxylase activities Was observed in cells treated With

methyl jasmonate relative to that in fungal elicitor-treated
cells. This result pointed to the hydroxylase reactions as a

potentially limiting step in capsidiol biosynthesis.
35

cially 5-epi-aristolochene synthase (EAS) (Vogeli and Chap

SUMMARY OF THE INVENTION

pell, Plant Physiol. 88:1291-1296, 1988; Back and Chappell,
In one aspect, the invention features several isolated cyto

Proc. Natl. Acad. Sci. USA. 93:6841-6845, 1996; Mathis et

al., Biochemistry 36:8340-8348, 1997; Starks et al., Science
277:1815-1820, 1997). EAS commits carbon to sesquiter
pene metabolism by catalyZing the cycliZation of famesyl
diphosphate (FPP) to 5-epi-aristolochene. HoWever, until the
present invention, the enZyme(s) responsible for the conver
sion of 5-epi-aristolochene to capsidiol has yet to be fully
identi?ed and characterized.
Biochemical evidence from previous studies in tobacco

40

45

the isolated nucleic acid molecule or vector.
50

of the hydroxylation steps being constitutive and the other
being mediated by an elicitor-inducible cytochrome P450
(FIG. 1). Because 1-deoxycapsidiol had been isolated from

In yet another aspect, the invention features a transgenic
plant or transgenic plant component including a nucleic acid
molecule of the invention, Wherein the nucleic acid molecule
is expressed in the transgenic plant or the transgenic plant

component. Preferably, the transgenic plant or transgenic
plant component is an angiosperm (for example, a monocot or

natural sources (Watson et al., Biochem. Soc. Trans. 11:589,

1983), Whitehead et al. (Phytochemistry 28:775-779, 1989),

substantial identity to these polypeptides), as Well as isolated
nucleic acid molecules that encode these P450s.
In related aspects, the invention features a vector (such as
an expression vector) including an isolated nucleic acid mol
ecule of the invention and a cell (for example, a prokaryotic
cell, such as Agrobacterium or E. coli, or a eukaryotic cell,

such as a mammalian, insect, yeast, or plant cell) including

(Whitehead et al., Phytochemistry 28:775-779, 1989) and
green pepper (Hoshino et al., Phytochemistry 38:609-613,
1995) have suggested that the oxidation of 5-epi-aris
tolochene to capsidiol occurs in a tWo step, process With one

chrome P450 polypeptides (such as CYP71D20, CYP71D21,
CYP73A27, CYP73A28, and CYP92A5, and P450s having

55

surmised that perhaps the biosynthesis of this intermediate

dicot). In preferred embodiments, the transgenic plant or
transgenic plant component is a solanaceous, maiZe, rice, or

Was due to pathogen induction of a corresponding hydroxy

cruciferous plant or a component thereof. The invention fur

lase. They therefore prepared synthetic 1-deoxycapsidiol and

ther includes a seed produced by the transgenic plant or
transgenic plant component, or progeny thereof.

reported a modest conversion of this compound to capsidiol
When fed to control or unelicited tobacco cell cultures. This

60

Was further supported by their observation that radiolabeled
5-epi-aristolochene Was only converted to capsidiol When fed

In another aspect, the invention features a method of pro
viding an increased level of resistance against a disease

caused by a plant pathogen in a transgenic plant. The method

to elicitor-induced cell cultures but not control cultures.

involves: (a) producing a transgenic plant cell including the

Whitehead et al. (Phytochemistry 28:775-779, 1989) there
fore concluded that the 3-hydroxylase, responsible for
hydroxylation of 5-epi-aristolochene at C3 to generate
1-deoxycapsidiol, Was pathogen/elicitor inducible, While the

nucleic acid molecule of the invention integrated into the
genome of the transgenic plant cell and positioned for expres

65

sion in the plant cell; and (b) groWing a transgenic plant from
the plant cell Wherein the nucleic acid molecule is expressed
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in the transgenic plant and the transgenic plant is thereby

most preferably 35 amino acids. For nucleic acids, the length
of comparison sequences Will generally be at least 50 nucle
otides, preferably at least 60 nucleotides, more preferably at
least 75 nucleotides, and most preferably 110 nucleotides.

provided With an increased level of resistance against a dis
ease caused by a plant pathogen.
In another aspect, the invention features a method for pro

Sequence identity is typically measured using sequence
analysis softWare (for example, Sequence Analysis Software

ducing an altered compound, the method including the steps
of contacting the compound With one or more of the isolated

Package of the Genetics Computer Group, University of Wis
consin Biotechnology Center, 1710 University Avenue,

polypeptides disclosed herein under conditions alloWing for
the hydroxylation, oxidation, demethylation, or methylation
of the compound and recovering the altered compound.

Madison, Wis. 53705, BLAST, or PILEUP/PRETTYBOX

In still another aspect, the invention features a hydroxylat

programs). Such software matches identical or similar

ing agent including any of the isolated polypeptides disclosed

sequences by assigning degrees of homology to various sub
stitutions, deletions, and/or other modi?cations. Conserva

herein.
In yet another embodiment, the invention features an iso

tive substitutions typically include substitutions Within the

lated nucleic acid molecule that speci?cally hybridizes under
highly stringent conditions to the complement of any one of
the sequences described in SEQ ID N012 (CYP71D20), SEQ
ID N014 (CYP71D21), SEQ ID N016 (CYP73A27), SEQ ID
N018 (CYP73A28), or SEQ ID N0112 (CYP92A5), Wherein

following groups: glycine alanine; valine, isoleucine, leu

cine; aspartic acid, glutamic acid, asparagine, glutamine;
serine, threonine; lysine, arginine; and phenylalanine,
tyrosine.
By an “isolated polypeptide” is meant a P450 polypeptide

such a nucleic acid molecule encodes a cytochrome P450

polypeptide.

20

In another aspect, the invention features a host cell express

ing a recombinant isoprenoid synthase and a recombinant

cytochrome P450. In preferred embodiments, the host cell
further expresses, independently or in combination, a recom

binant acetyltransferase, methyltransferase, or fatty acyl

25

transferase. In other preferred embodiments, the host
expresses an endogenous or recombinant cytochrome reduc
tase. Preferably, the host cell is a yeast cell, a bacterial cell, an
insect cell, or a plant cell.
In a related aspect, the invention features a method for

30

(for example, a CYP71D20 (SEQ ID N01 1), CYP71D21
(SEQ ID N013), CYP73A27 (SEQ ID N015), CYP73A28
(SEQ ID N017), or CYP92A5 (SEQ ID N011 1) polypeptide)
that has been separated from components that naturally
accompany it. Typically, the polypeptide is isolated When it is
at least 60%, by Weight, free from the proteins and naturally
occurring organic molecules With Which it is naturally asso
ciated. Preferably, the preparation is at least 75%, more pref
erably at least 90%, and most preferably at least 99%, by
Weight, a P450 polypeptide. An isolated P450 polypeptide
may be obtained, for example, by extraction from a natural
source (for example, a plant cell); by expression of a recom

producing an isoprenoid compound, the method including the

binant nucleic acid encoding a P450 polypeptide; or by

steps of: (a) culturing a cell that expresses a recombinant
isoprenoid synthase and a recombinant cytochrome P450
under conditions Wherein the isoprenoid synthase and the
cytochrome P450 are expressed and catalyze the formation of

chemically synthesizing the protein. Purity can be measured
by any appropriate method, for example, column chromatog
raphy, polyacrylamide gel electrophoresis, or by HPLC
35

analysis.

an isoprenoid compound not normally produced by the cell;
and (b) recovering the isoprenoid compound. In preferred

By “derived from” or “obtained from” is meant isolated
from or having the sequence of a naturally-occurring

embodiments, the host cell further expresses a recombinant

sequence (e.g., cDNA, genomic DNA, synthetic, or combi
nation thereof).

acetyltransferase, a recombinant methyltransferase, or a

recombinant fatty acyltransferase. In other preferred embodi

40

ments, the host cell expresses an endogenous or recombinant

By “isolated nucleic acid molecule” is meant a nucleic acid
molecule, e.g., a DNA molecule, that is free of the nucleic

cytochrome reductase. Preferably, the host cell is a yeast cell,

acid sequence(s) Which, in the naturally-occurring genome of

a bacterial cell, an insect cell, or a plant cell.

the organism from Which the nucleic acid molecule of the
invention is derived, ?ank the nucleic acid molecule. The
term therefore includes, for example, a recombinant DNA
that is incorporated into a vector; into an autonomously rep
licating plasmid or virus; or into the genomic DNA of a

In yet another aspect, the invention features an isoprenoid

compound produced according to the above-mentioned
methods.
By “P450 polypeptide,” “cytochrome P450, ” or “P450” is
meant a polypeptide that contains a heme-binding domain
and shoWs a C0 absorption spectra peak at 450 nm according
to standard methods, for example, those described herein.

45

prokaryote or eukaryote; or that exists as a separate molecule
(for example, a cDNA or a genomic or cDNA fragment pro

lase activity, dual hydroxylase activity, demethylase activity,

duced by PCR or restriction endonuclease digestion) inde
pendent of other sequences. The term “isolated nucleic acid
molecule” also includes a recombinant DNA Which is part of

or oxidase activity. Such enzymatic activities are determined
using methods Well knoWn in the art.

a hybrid gene encoding additional polypeptide sequence.
By “speci?cally hybridizes” is meant that a nucleic acid

50

Such P450s may also include, Without limitation, hydroxy

By “polypeptide” is meant any chain of amino acids,

55

sequence is capable of hybridizing to a DNA sequence at least

regardless of length or post-translational modi?cation (for
example, glycosylation or phosphorylation).

under loW stringency conditions, and preferably under high
stringency conditions. For example, high stringency condi

By “substantially identical” is meant a polypeptide or
nucleic acid exhibiting at least 80 or 85%, preferably 90%,

tions may include hybridization at approximately 420 C. in
about 50% forrnamide, 0.1 mg/ml sheared salmon sperm
DNA, 1% SDS, 2><SSC, 10% Dextran sulfate, a ?rst Wash at
approximately 650 C. in about 2><SSC, 1% SDS, folloWed by

more preferably 95%, and most preferably 97%, or even 98%

60

identity to a reference amino acid sequence (for example, the
amino acid sequence shoWn in SEQ ID NOS11, 3, 5, 7, and 1 1)
or nucleic acid sequence (for example, the nucleic acid

sequences shoWn in SEQ ID NOS12, 4, 6, 8, and 12, respec
tively). For polypeptides, the length of comparison sequences
Will generally be at least 16 amino acids, preferably at least 20
amino acids, more preferably at least 25 amino acids, and

a second Wash at approximately 650 C. in about 0.1><SSC.

Alternatively high stringency conditions may include hybrid
65

ization at approximately 420 C. in about 50% forrnamide, 0.1
mg/ml sheared salmon sperm DNA, 0.5% SDS, 5>< SSPE, 1><
Denhardt’s, folloWed by tWo Washes at room temperature in
2><SSC, 0.1% SDS, and tWo Washes at between 55-600 C. in
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0.2><SSC, 0.1% SDS. Reducing the stringency of the hybrid

plasmas, fungi, insects, nematodes, viruses, and viroids. Plant

iZation conditions may involve lowering the Wash tempera

diseases caused by these pathogens are described in Chapters
11-16 of Agrios, Plant Pathology, 3rd ed., Academic Press,
Inc., NeW York, 1988.

ture and/or Washing at a higher concentration of salt. For

example, loW stringency conditions may include Washing in

By “increased level of resistance” is meant a greater level
of resistance to a disease-causing pathogen in a transgenic
plant (or cell or seed thereof) of the invention than the level of
resistance relative to a control plant (for example, a non

2><SSC, 0.1% SDS at 400 C.
By “transformed cell” is meant a cell into Which (or into an
ancestor of Which) has been introduced, by means of recom

binant DNA techniques, a DNA molecule encoding (as used
herein) a P450 polypeptide.
By “positioned for expression” is meant that the DNA

transgenic plant). In preferred embodiments, the level of

molecule is positioned adjacent to a DNA sequence Which

resistance in a transgenic plant of the invention is at least 20%
(and preferably 30% or 40%) greater than the resistance of a

directs transcription and translation of the sequence (i.e.,
facilitates the production of, for example, a P450 polypeptide,

resistance to a disease-causing pathogen is 50% greater, 60%

a recombinant protein, or an RNA molecule).

greater, and more preferably even 75% or 90% greater than a

control plant. In other preferred embodiments, the level of

By “reporter gene” is meant a gene Whose expression may

control plant; With up to 100% above the level of resistance as
compared to a control plant being mo st preferred. The level of
resistance is measured using conventional methods. For
example, the level of resistance to a pathogen may be deter

be assayed; such genes include, Without limitation, beta-glu

curonidase (GUS), luciferase, chloramphenicol transacety
lase (CAT), green ?uorescent protein (GFP), beta-galactosi
dase, herbicide resistant genes, and antibiotic resistance
genes.

20

By “expression control region” is meant any minimal
sequence suf?cient to direct transcription. Included in the
invention are promoter elements that are suf?cient to render

promoter-dependent gene expression controllable for cell-,
tissue-, or organ-speci?c gene expression, or elements that

By “puri?ed antibody” is meant antibody Which is at least
25

60%, by Weight, free from proteins and naturally-occurring

30

organic molecules With Which it is naturally associated. Pref
erably, the preparation is at least 75%, more preferably 90%,
and most preferably at least 99%, by Weight, antibody, for
example, an acquired resistance polypeptide-speci?c anti
body. A puri?ed P450 antibody may be obtained, for

are inducible by external signals or agents (for example,
light-, pathogen-, Wound-, stress-, or hormone-inducible ele
ments or chemical inducers such as salicylic acid (SA) or

2,2-dichloro isonicotinic acid (INA)); such elements may be
located in the 5' or 3' regions of the native gene or engineered

mined by comparing physical features and characteristics (for
example, plant height and Weight, or by comparing disease
symptoms, for example, delayed lesion development,
reduced lesion siZe, leaf Wilting and curling, Water-soaked
spots, and discoloration of cells) of transgenic plants.

example, by a?inity chromatography using a recombinantly
produced P450 polypeptide and standard techniques.

into a transgene construct.

By “operably linked” is meant that a gene and a regulatory
sequence(s) are connected in such a Way as to permit gene

By “speci?cally binds” is meant an antibody Which recog

expression When the appropriate molecules (for example,

niZes and binds a P450 protein but Which does not substan

transcriptional activator proteins) are bound to the regulatory

35

sequence(s).
By “plant cell” is meant any self-propagating cell bounded
by a semi-permeable membrane and typically is one contain
ing a plastid. Such a cell also requires a cell Wall if further
propagation is desired. Plant cell, as used herein includes,

tially recogniZe and bind other molecules in a sample, for
example, a biological sample, Which naturally includes a
P450 protein such as CYP71D20, CYP71D21, CYP73A27,
CYP73A28, or CYP92A5.

Other features and advantages of the invention Will be
40

Without limitation, algae, cyanobacteria, seeds, suspension
cultures, embryos, meristematic regions, callus tissue, leaves,
roots, shoots, gametophytes, sporophytes, pollen, and

apparent from the folloWing description of the preferred
embodiments thereof, and from the claims.
BRIEF DESCRIPTION OF THE DRAWINGS

microspores.
By “plant component” is meant a part, segment, or organ
obtained from an intact plant or plant cell. Exemplary plant

45

components include, Without limitation, somatic embryos,
leaves, stems, roots, ?oWers, tendrils, fruits, scions, and root

aristolochene synthase (EAS), and is subsequently hydroxy

stocks.

By “transgene” is meant any piece of DNA Which is
inserted by arti?ce into a cell and typically becomes part of
the genome, for example, the nuclear or plastidic genome, of
the organism Which develops from that cell. Such a transgene
may include a gene Which is partly or entirely heterologous
(i.e., foreign) to the transgenic organism, or may represent a
gene homologous to an endogenous gene of the organism.

50

lated at C1 and C3 to form capsidiol.
FIG. 2 is a graph shoWing an induction time course for

sesquiterpene cyclase enZyme activity and sesquiterpene
hydroxylase activity in cellulase-treated cell cultures. Ses

quiterpene cyclase (5-epi-aristolochene synthase, EAS)
55

enZyme activity Was determined in extracts prepared from

control (open squares) and elicitor-treated (closed squares)
cells collected at the indicated time points. Sesquiterpene
hydroxylase activity Was determined using an indirect assay

By “transgenic” is meant any cell Which includes a DNA
sequence Which is inserted by arti?ce into a cell and becomes

part of the genome of the organism Which develops from that
cell. As used herein, the transgenic organisms are generally

FIG. 1 is a schematic diagram of a proposed alternative

pathWay for the biosynthesis of capsidiol in elicitor-treated
Nicoliana Zabacum cells. 5-epi-aristolochene is synthesiZed
from FPP by the action of a sequiterpene cyclase, 5-epi

for control (open circles) and elicitor-treated (closed circles)

transgenic plants and the DNA (transgene) is inserted by

cells. Cell cultures Were incubated With [3H]-5-epi-aris
tolochene for 3 hours ending at the indicated time points

arti?ce into the nuclear or plastidic genome. A transgenic

before quantifying the incorporation of radioactivity into

plant according to the invention may contain one or more

extracellular capsidiol, a dihydroxylated form of aris
tolochene (Mandujano-ChaveZ et al., Arch. Biochem. Bio

60

engineered traits.
By “pathogen” is meant an organism Whose infection of
viable plant tissue elicits a disease response in the plant tissue.

Such pathogens include, Without limitation, bacteria, myco

65

phys. 381:285-294, 2000).
FIG. 3 is a series of graphs shoWing the dose dependent

inhibition of 5-epi-aristolochene hydroxylase activity by
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ancymidol and ketoconaZole. Cell cultures Were incubated in

Biophys. 368:181-192, 1999). AtCYP701A3 (AAC39505)

the presence of cellulase (0.5 ug/mL) plus the indicated con
centrations of ancymidol (A) or ketoconaZole (B) for 12 hours

encodes for kaurene oxidase, Which catalyZes a 3-step reac
tion including a hydroxylation folloWed by oxidation of a

prior to measuring the in vivo 5-epi-aristolochene hydroxy

diterpene (HelliWell et al., Plant Physiol. 119:507-510,

lase activity in the cell suspension cultures (squares), or the
EAS enzyme activity in extracts prepared from the collected
cells (triangles). The in vitro activity of a puri?ed EAS prepa
ration (Back and Chappell, J. Biol. Chem. 270:7375-7381,

1999). ShoWn are sequences from Menlha piperila

1995) Was also measured at the indicated inhibitor concen
trations as an additional test for non-speci?c effects of these

(MpCYP71D13; SEQ ID NO139), Menlha spicala
(MsCYP71D18; SEQ ID NO:40), Nepela racemosa
(NrCYP71A5vb 1; SEQ ID NO:41), Nicoliana Zabacum
(NtCYP71D20; SEQ ID NO:1), Persea americana
(PaCYP71A1; SEQ ID NO:42), and Arabidopsis Zhaliana

inhibitors (circles).

(CYP701A3; SEQ ID NO:43). Conserved residues are

FIG. 4A is a schematic diagram of the primary structure of
a generaliZed cytochrome P450 With conserved domains used

shaded.

for the design of PCR primers highlighted (SEQ ID NOS:26

DETAILED DESCRIPTION

29).
Capsidiol is a bicyclic, dihydroxylated sesquiterpene pro

FIG. 4B is a list of the degenerate P450-speci?c primers
(SEQ ID NOSz30-36) that Were used in various combinations

duced by several Solanaceous species in response to a variety
of environmental stimuli. It is the primary antimicrobial com

With vector speci?c primers in the ampli?cation of cyto
chrome P450 cDNA fragments.
FIG. 4C is a scanned image of an ethidium bromide-stained

20

agarose gel shoWing the PCR. products ampli?ed from a
directional cDNA library prepared With mRNA isolated from
elicitor-treated cells using the degenerate primer GRRXCP

(A/G)-for (SEQ ID NO:35) and the T7 vector-speci?c primer
(SEQ ID NO:37). The T3 vector-speci?c primer is also shoWn

25

(SEQ ID NO:38).

a dose dependent inhibition of activity by ancymidol and

time course for CYP71D, CYP73A, CYP82E, CYP92A, and
EAS transcript accumulation in elicitor treated cells. Total

ketoconaZole, tWo Well-characterized inhibitors of cyto
30

fractionated by agarose gel electrophoresis under denaturing

families (CYP71, CYP73, CYP82, and CYP92) Were ampli
35

FIG. 6 is a series of graphs shoWing carbon monoxide (CO)
difference spectra of the microsomal fraction isolated from

yeast expressing the CYP92A5 (A) and CYP71D20 (B)
cDNAs. Expression of the respective plasmid constructs

chrome P450 enZymes. Using degenerate oligonucleotide
primers designed to the Well-conserved domains found
Within most P450 enZymes, including the heme binding
domain, cDNA fragments representing four distinct P450

conditions, and transferred to a nylon membrane before prob

ing With the respective full-length cDNAs. The uniformity of
sample loading Was veri?ed by ethidium bromide staining of
ribosomal RNA (Loading control).

capsidiol.
Accordingly, an in vivo assay for 5-epi-aristolochene
hydroxylase-activity Was developed and used to demonstrate

FIG. 5 is a series of Northern blots shoWing the induction

RNA Was extracted from tobacco suspension cells incubated
With the cellulase elicitor for the indicated durations, siZe

pound produced by Nicoliana Zabacum in response to fungal
elicitation, and it is formed via the isoprenoid pathWay from
5-epi-aristolochene. Much of the biosynthetic pathWay for
the formation of this compound has been elucidated, except
for the enZyme(s) responsible for the conversion of the allylic
sesquiterpene 5-epi-aristolochene to its dihydroxylated form,

?ed from a cDNA library prepared against mRNA from elici
tor-treated cells using PCR. The PCR fragments Were subse

quently used to isolate full-length cDNAs (CYP71D20 (SEQ
ID NO: 2) and D21 (SEQ ID NO: 4), CYP73A27 (SEQ ID
NO: 6) and A28 (SEQ ID NO: 8), CYP82E1 (SEQ ID NO:
40

10), and CYP92A5 (SEQ ID NO: 12)), and these in turn Were

engineered into the yeast (WAT11) cells Was induced by a

used to demonstrate that the corresponding mRNAs Were all

galactose treatment, folloWed by isolation of microsomal
preparations. The difference adsorption spectra of
microsomes incubated in the presence (solid lines) and

induced in elicitor-treated cells, albeit With different induc
tion patterns.

absence (broken lines) of carbon monoxide Was determined.
FIG. 7 is a series of gas chromatograms of the reaction
products formed upon incubation of microsomes isolated
from WAT11 yeast cells containing the CYP71D20 expres
sion construct (A and C) or vector control DNA (B and D)
With sesquiterpene substrates. Microsomes isolated from the
indicated yeast lines Were incubated With 5-epi-aristolochene

45

Inhibition of the 5-epi-aristolochene to Capsidiol Conversion
50

Using an indirect assay, a detailed induction time course of

mined relative to that of EAS activity (FIG. 2), the Well
55

hours and reaches its maximal level Within 15 to 18 hours of
elicitor-treatment. Similar to the EAS enZyme activity, 5EAH

other plant terpene hydroxylases (SEQ ID NOSz39-43).

mono-hydroxylation at C6 and C3 of limonene, a cyclic

monoterpene, respectively (Lupien et al., Arch. Biochem.

characteriZed sesquiterpene cyclase activity that catalyZes the
formation of 5-epi-aristolochene from FPP (FIG. 1). Using
assays for EAS and 5EAH, EAS activity is not detectable in
control cell cultures, but is induced signi?cantly Within 3

sequence of Nicoliana Zabacum 5-epi-aristolochene (sesquit
erpene) hydroxylase NtCYP71D20 (SEQ ID NO: 1) With

NrCYP71A5v1 (GenBank accession number CAA70575)
catalyZes the mono-hydroxylation of nerol and geraniol, lin
ear monoterpenes, While PaCYP71A1 (A35867) catalyZes
the epoxidation of these substrates (Hallahan et al., Biochim.
Biophys. Acta. 1201 194-100, 1994). MsCYP71D18
(AAD44150) and MpCYP7 1 D13 (AAD44151) catalyze the

by P450 Antagonists
5EAH activity in elicitor-induced cell cultures Was deter

(A and B) or 1-deoxycapsidiol (C and D) in the presence
(solid lines) or absence (dashed lines) of NADPH. The iden
tities of 5-epi-aristolochene, 1-deoxycapsidiol, and capsidiol
Were veri?ed by mass spectrometry.
FIG. 8 is a sequence comparison of the amino acid

There noW folloWs a description of the cloning of several
P450s from Nicoliana Zabacum. These examples are provided
for the purpose of illustrating the invention, and are not to be
considered as limiting.

60
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activity Was negligible in control cell cultures. Nonetheless,
after an apparent lag phase of 8 hours, a rapid induction of
hydroxylase activity Was observed 10 to 15 hours post elicitor
addition to the cell cultures, reaching a maximum by 18 hours
folloWed by a rather gradual decline of 10 to 20% over the
next 8 hours.

Tobacco cell suspension cultures treated With cellulase
plus varying concentrations of ancymidol or ketoconaZole

US 7,405,057 B2
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ability to convert exogenous supplied [3H] labeled 5-epi

cDNA library by hybridiZation With the CYP71 and CYP73
gene fragments yielded four full-length cDNAs, tWo

aristolochene to radiolabeled capsidiol during a subsequent 3

CYP71Ds and tWo CYP73As. The former clones Were des

hour incubation period (FIG. 3). Apparent activity of 5EAH
Was inhibited in a dose-dependent manner With approxi

ignated CYP71D20 and CYP71D21, and the latter Were des
ignated CYP73A27 and CYP73A28. The other tWo cDNA

mately 50% inhibition by either 25 uM ancymidol or keto
conaZole, and more than 80% by 75 uM ancymidol and 95%

the GenBank database, CYP82E1 and CYP92A3. These tWo

by 100 uM ketoconaZole (FIGS. 3A and B). Importantly,

cDNAs Were cloned using speci?c primers designed With the
help of the available sequence information to amplify the

Were pre-incubated for 12 hours before measuring the cells’

fragments corresponded to tobacco cDNAs already found in

neither the in vitro activity of recombinant EAS nor the induc
tion of EAS in the elicitor-treated cell cultures Was signi?
cantly affected by ancymidol at concentrations as high as 100

full-length cDNA
Induction of Cytochrome P450 mRNAs in Elicitor-treated
Cells
To correlate a biochemical role for P450s in sesquiterpene
metabolism, RNA blot analyses Were used to determine the
steady-state levels of the mRNAs coding for all four of the
cytochrome P450 clones and EAS in control and elicitor
treated cells (FIG. 5). The mRNAs for all four of the P450s
Were rapidly and transiently induced With slightly different

uM (FIG. 3A). KetoconaZole also does not appear to affect the

in vitro activity of EAS. HoWever, the inducibility of cyclase
activity in elicitor-treated cell extracts Was inhibited by keto

conaZole at concentrations above 50 uM (FIG. 3B). There
fore, the speci?city of ketoconaZole as an inhibitor of P450
type reactions should be assessed at or beloW a concentration

of 50 uM under these experimental conditions.
Isolation of Elicitor-inducible Cytochrome P450 cDNAs
A tWo-step approach for the isolation of candidate P450

20

cDNAs Was folloWed. A PCR strategy Was ?rst employed

mRNA remained high throughout the duration of the experi

isolated from elicitor-induced cells as the template and
25

cytochrome P450s from multiple families across kingdoms
Were used to identify conserved regions to Which a series of

degenerate primers Were prepared (FIGS. 4A and B). In clon
ing experiments, 450 to 550 bp products Were expected from
reactions utilizing the primer prepared to the heme-binding
domain (GRRXCP(A/G)) (SEQ ID NOS:27 and 28) and the
T7 vector primer (FIG. 4C). The mixtures of reaction prod

30
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ods EnZymol. 272:51-64, 1996) and the expression ofeach in
WAT11, a yeast line containing an integrated Arabidopsis
Zhaliana cytochrome reductase gene (Pompon et al., Methods
EnZymol. 272:51-64, 1996; Urban et al., J. Biol, Chem. 272:
19176-19186, 1997), Was determined. Engineering the

these corresponded to typical plant P450 family members of
the CYP71, CYP73, CYP92, and CYP82 classes. Each of

CYP73A27 cDNA required an extra modi?cation because of

an unusually long N-terminus With several hydrophilic resi
dues that may interfere With proper intracellular targeting

(Nedelkina et al., Plant Mol. Biol. 39:1079-1090, 1999). This
45

4-hydroxylase previously demonstrated to express Well in

50

Full-length cDNAs cloned from an elicited cDNA library

CYP71D20

CYP71D7 (S. chacoense)
CYP71D7 (S. chacoense)

CYP73A27

CYP73A15 (R vulgaris)

CYP73A28

CYP73A15 (R vulgaris)

76.5

88.8

76.3

88.8

CYC1 promoter (Guarente et al., Proc. Natl. Acad. Sci.
USA. 79:7410-7414, 1982), and expression Was compared
to yeast transformed With the parent pYeDP60 vector (con
trol) alone.
After induction With galactose for approximately 16 hours,

79.4

92.6

control cells and cells containing the various P450 constructs
Were collected, and microsomes prepared from each Were

79.2

92.4

% identity % similarity
55

Gen EMBL U48435
Gen EMBL Y09447
60

Gen EMBL Y09447

CYP82E1

CYP82E1 (N. labacum)

100.0

100.0

95.5

98.6

Gen EMBL AB015762

CYP92A5

CYP92A3 (N. labacum)

1996). Expression of all these cDNAs Was under the control

of the glucose-repressible, galactose-inducible GAL10

Gen EMBL U48435

CYP71D21

unusual leader sequence therefore Was replaced With the
membrane anchoring sequence of CYP73A1, a cinnamate

yeast (Fahrendorf and Dixon, Arch. Biochem. Biophys. 305:
509-515, 1993; Pompon et al., Methods EnZymol. 272:51-64,

TABLE 1

Cytochrome P450 Nearest relative/
cDNA clone
accession number

Functional Identi?cation of CYP71D20 as 5-epi-aris

To ascribe functional identity to the various P450 cDNAs,
full-length cDNAs for CYP7 1 D20, CYP82E1 and CYP92A5
Were inserted into the yeast expression vector pYeDP60 (Ur
ban et al., Biochimie 72:463-472, 1990; Pompon et al., Meth

P450 enZymes as revealed by BlastX database searches, and

these PCR fragments Was isolated multiple times in separate
experiments. In addition, We isolated fall-length cDNAs for
these P450 family members. Table 1 compares the similarity
and identity of the ?ll-length cDNAs of P450 family members
With those of their nearest family member in the GenBank
database. In addition, FIG. 8 shoWs an amino acid alignment
of several terpene cytochrome P450s. Alignments Were per
formed using the algorithm of the MACVECTOR softWare
suite.

ment, the CYP73A27 mRNA Was negligible in cells 24 hours
after elicitor-treatment. In contrast, the CYP71D mRNA Was
more rapidly induced than the EAS mRNA, reached its maxi
mum 6 to 9 hours after elicitation, and Was declining by 12
hours When the EAS mRNA level Was still very high.

tolochene Hydroxylase

ucts Were shotgun cloned, and approximately 100 of the
cloned PCR fragments Were sequenced. About half of the

sequenced DNAs contained signature sequences typical of

CYP73A27 mRNA, for instance, displayed an induction pat
tern similar to that of EAS With the maximum mRNA level
occurring 9 to 12 hours after elicitation. While the EAS

using a directional cDNA library prepared against mRNA

degenerate PCR primers (FIG. 4). Sequence alignments of

time courses relative to one another and to the EAS mRNA.

Gen EMBL X96784

analyZed for general P450 expression by CO-difference spec
troscopy (Omura and Sato, J. Biol. Chem. 239:2370-2378,
1964). Microsomes prepared from cells containing the
CYP71D20 (FIG. 6A) and CYP92A5 (FIG. 6B) constructs
both shoWed characteristic CO difference spectra With peaks
at 450 nm, indicating that the encoded proteins Were assem

65

The cloned fragments Were used in a second step to isolate

full-length clones from the cDNA library. Screening the

bling properly With their heme cofactor. Using the extinction
coel?cient of 91 mM‘1 cm‘1 for heme binding proteins
(Omura and Sato, J. Biol. Chem. 239:2370-2378, 1964), it
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Was determined that approximately 107 pmol of CYP71D20
and 268 pmol of CYP92A5 Were expressed in the yeast cells

Control and elicitor-treated cells Were then incubated With

per milligram of total yeast protein.

[3H]-5-epi-aristolochene (approximately 100,000 dpm at 2.5

as capsidiol. Obvious by its absence, no reaction product

pM) for 3 hour periods at various points during an induction
time course before collecting the cell and media samples.
Detection and quanti?cation of capsidiol in the extracellular
culture media Was performed as reported previously (Chap

having a retention time similar to deoxycapsidiol Was detect

pell et al., Phytochemistry 26:2259-2260, 1987), and the

able in the 5-epi-aristolochene incubations (FIG. 7). Co-in
jection of authentic capsidiol With the respective reaction

amount of radioactivity incorporated into capsidiol Was deter
mined. For these determinations, samples Were separated by

products resulted in a single GC peak having a 16.2 minute
retention time, identical to capsidiol. Mass spectra patterns
for the separate reaction products Were identical to that for the

from the plate for scintillation counting.

Both 5-epi-aristolochene and 1-deoxycapsidiol Were
metabolized to only one product With the same retention time

TLC, and the zones corresponding to capsidiol Were scraped
Inhibition studies Were performed by the addition of the

P450 inhibitors ancymidol (Coolbaugh et al., Plant Physiol.
62:571-576, 1978; Hoshino et al., Phytochemistry 38:609
613, 1995) and ketoconazole (Hoshino et al., Phytochemistry
38:609-613, 1995; Rademacher, Annu. Rev. Plant Physiol.
Plant Mol. Biol. 51:501-531, 2000) directly to the cell cul

capsidiol standard (EIMS m/z 236, 221, 203, 185, 175, 163,
157, 133, 121, 107, 93, 79, 67, 55, 43, 41).
The in vivo assay data presented in FIGS. 2 and 3 of the
current Work indicate that the conversion of 5-epi-aris
tolochene is catalyzed by at least one inducible cytochrome
P450 mediated reaction.

tures or enzyme assay mix. Cell cultures Were incubated in

Furthermore, any of the cytochrome p450 polypeptides
described herein may include one or more hydroxylase activi

20

ties Which can incorporate hydroxyl groups into at least tWo
distant sites on an isoprenoid compound. The addition of

these hydroxyl groups may occur, for example, sequentially,
by adding a hydroxyl group ?rst to one site and then the other,
in either order. Moreover, such hydroxylases may be mutated
to limit their ability to hydroxylate a substrate at only one site,
or, alternatively, to provide stereochemical speci?city to their

sidiol Was determined as described above. To evaluate sec
25

30

Chemicals
Standard laboratory reagents Were purchased from Becton

Dickinson Microbiology Systems (Sparks, Md.), FisherBio
tech (Fair LaWn, N1.) and Sigma Chemical Company (St.

ondary effects of these inhibitors, the level of inducible ses

quiterpene cyclase activity in the collected cells Was
determined according to (Vogeli et al., Plant Physiol. 93: 182

hydroxylating activity.
The above-described experiments Were performed using
the folloWing materials and methods.

the presence of cellulase (0.5 pg/ml) and indicated concen
trations of ancymidol or ketoconazole for 12 hours prior to the
addition of [3H]-5-epi-aristolochene. After a further 3 hour
incubation period, the cells and media Were collected. The
amount of radioactivity incorporated into extracellular cap

187, 1990), as Well as in vitro assays With puri?ed recombi
nant EAS (Back et al., Arch. Biochem. Biophys. 315:527
532, 1994) incubated With the indicated concentrations of
ancymidol and ketoconazole.

All experiments Were replicated in several independent
trials. While the absolute values presented may have varied
betWeen experiments by as much as 50%, the trends and time
35

Louis, Mo.).

courses Were consistent throughout.

Construction of an Elicitor-induced cDNA Library
Cell cultures Were incubated With fungal elicitor (0.5 pg

Biological Materials and Induction Treatments
Nicoliana Zabacum cv. KY14 plants and cell suspension

cellulase/ml) for 6 hours before collecting the cells by ?ltra

cultures Were used. Cell suspension cultures Were maintained

tion. The cells Were kept frozen at —80° C. until total RNA Was

in modi?ed Murashige-Skoog (Vogeli and Chappell, Plant
Physiol. 88:1291-1296, 1988). Cultures in their rapid phase

40

of groWth (3 days old) Were used for all experiments. At the

extracted from them using Trizol (Life Technologies, Rock
ville, Md.) according to the manufacturer’s instructions. Poly
(A)+RNA Was puri?ed by tWo rounds of oligo (dT) cellulose

indicated times, cells Were collected and separated from

column chromatography (Life Technologies, Rockville,

media by vacuum ?ltration and stored at —80° C.
Induction treatments Were performed by the addition of the

Md.). cDNA synthesis and library construction Were subse
quently carried out using the UNI-ZAP XR library kit (Strat
agene, La Jolla, Calif.), according to manufacturer’s instruc

45

fungal elicitors, cellulase (Trichoderma viride, Type RS,
Onozuka) or paraciticein (O’Donohue et al., Plant Mol. Biol.
27:577-586, 1995) at the indicated concentrations. Paraciti

tions.

PCR Cloning Strategy

cein Was puri?ed from E. coli cells overexpressing a recom

binant paraciticein protein containing a carboxy-terminal his
tidine puri?cation tag.

50

In vivo 5-epi-aristolochene Hydroxylase Assay and Inhibi
tion Studies
5-epi-aristolochene hydroxylase-activity Was measured as

the incorporation of [3H] -5-epi-aristolochene into extracellu
lar capsidiol by intact cells. [3H]-5-epi-aristolochene Was
produced by incubating an excess of [1 -3 H] famesyl diphos
phate (1 pM, 20.5 Ci/mmol) With recombinant 5-epi-aris
tolochene synthase (Back et al., Arch. Biochem. Biophys.

55

Cytochrome P450 cDNA fragments Were ampli?ed from
the elicitor-induced cDNA library using various combina
tions of degenerate forWard and reverse primers With the
vector-speci?c T3 and T7 primers. The template DNA Was
prepared from a 500 pl aliquot of the elicitor-induced cDNA
library (3><106 pfu/pl) by heat denaturation at 70° C. for 10

minutes, folloWed by phenol/ chloroform extraction, ethanol
precipitation and re-suspension in 500 pl of sterile, deionized
Water. Ampli?cation reactions Were performed in 50 pl vol
umes containing 50 mM KCl; 10 mM Tris-HCl, pH 8.8; 1.5
60

mM MgCl2; 200 pM of each dNTP; 2 pl template DNA; 20

315:527-532, 1994; Rising et al., J. Am. Chem. Soc. 122:
1861 -1 866, 2000). The hexane extractable radioactivity from

pmol each of forWard and reverse primer; and 1 unit Taq

reactions Was treated With a small amount of silica to remove

Were preheated at 94° C. for 2 minutes, folloWed by thirty-?ve
cycles of denaturing at 94° C. for 1 minute, annealing at 50°
C. for 1 minute 30 seconds, and polymerization at 72° C. for

Polymerase (Life Technologies, Rockville, Md.). Reactions

any famesol or residual FPP before quantifying the yield of

radioactive 5-epi-aristolochene by liquid scintillation count
ing. The hexane solvent Was removed under a gentle stream of
N2 gas, and the dried residue Was re-dissolved in acetone.

65

2 minutes. The reactions Were completed by a 10-minute
extension at 72° C. Aliquots of the reaction products Were
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examined for DNA products by agarose gel fractionation, and
ligated directly into the pGEM-T Easy vector (Promega,

TCC-3' (SEQ ID NO: 17) and 5'-GGGGAATTCTTACT
CTCGAGAAGGTTGATAAGG-3' (SEQ ID NO: 18); for

Madison, Wis.). Resulting recombinant plasmids containing

the CYP82E1 cDNA 5'-CCCGGATCCATGTATCATCT

insert DNAs Within the expected size range Were sequenced

using T7 and Sp6 primers.
DNA Sequencing

TCTTTCTCCC-3' (SEQ ID NO:
5

19) and 5'-GGG

GAATTCTCAATATTGATAAAGCGTAGGAGG-3' (SEQ
ID NO: 20); and for the CYP92A3 cDNA 5'-CCC

GGATCCATGCAATCCTTCAGCTTGGTTTCC-3'

All the DNA sequencing reactions Were performed using

(SEQ

ID NO: 21) and 5'-GGGGAGCTCTCACTCGCAAGAA
GATTGATAAGG-3' (SEQ ID NO: 22). TWo long, over

the BIGDYETM Terminator Cycle sequencing kit (Perkin
Elmer, Wellesley, Mass.) With the sequences being read on an
automated ABI Prism 310 Genetic Analyzer (Applied Bio
systems, Foster City, Calif.). Computer assessment of the
DNA sequence information Was performed using the

lapping (italicized) primers 5'-GCCATTATCGGCGCAA
TACTAATCTCCAAACTCCGCGGTAAAAAATTCAAG

CTCCCACCTGGTCCAACAGCAGTC-3' (SEQ ID NO:
23) and 5'-GGGGGATCCATGGACCTCCTCCTCATAGA

MACVECTOR (Oxford Molecular, Madison, Wis.) softWare

package.

AAAAACCCTCGTCGCCTTATTCGCCGCCATTATCG

cDNA Library Screening

minal sequence of CYP73A1 (GenEMBL Z 17369) up to the
hinge region Were used for the modi?cation of the membrane

GCGCAATACTA-3' (SEQ ID NO: 24) coding for the N-ter

The cDNA library Was screened With digoxigenin labeled

probes. A 258 bp DNA fragment ampli?ed from the pGEM

anchoring segment of CYP73A27 to avoid possible problems

deg6.4 clone using gene-speci?c forWard (5'-GGCG

With intracellular targeting due to the unusual N-terminus
(Nedelkina et al., 1999); the reverse primer used for both
ampli?cations Was 5'-GGGGAGCTCTTATGCAGCAAT
AGGCTTGAAGAC-3' (SEQ ID NO: 25). CYP71D20 and
CYP73A27 Were ampli?ed using full-length cDNA tem
plates, Whereas CYP82E1 and CYP92A5 Were ampli?ed

GAGAATTTGTCCTGGAATGTCATTTGGTTTAG-3'

20

(SEQ ID NO: 13)) and reverse (5'-GTACAATAGTGAGGT
TGACAATG-3' (SEQ ID NO: 14)) primers; and a 374 bp
DNA fragment ampli?ed from the pBKS-CYPB3.843 clone

With speci?c forWard (5'-GGTGGTTGTGAATGCATG-3'
(SEQ ID NO: 15)) and reverse (5'-TTATGCAGCAATAG
GCTTGAAGACA-3' (SEQ ID NO: 16)) primers, Were used

25

directly from the cDNA library template. Ampli?cations

30

Were performed in 50 pl reactions containing 1>< Pfx ampli
?cation buffer; 1 mM MgSO4; 300 pM of each dNTP; 10 ng
template DNA; 20 pmol each of forWard and reverse primer;
and 1.25 units PLATINUM® Pfx Polymerase (Life Tech
nologies, Rockville, Md.). Reactions Were preheated at 94°

to screen for CYP71Ds. The probes Were labeled With digoxi

genin-11-dUTP using the PCR DIG Labeling Mix (Roche
Molecular Biochemicals, Indianapolis, Ind.), hybridized to
plaque lifts of the cDNA library plated at approximately
10,000 PFUs per 150 mm plate, and Was hybridization

C. for 2 minutes, folloWed by thirty-?ve cycles of denaturing

detected With the DIG detection system according to the
manufacturer’ s instructions (Roche Molecular Biochemicals,

at 94° C. for 15 seconds, annealing at 55° C. for 30 seconds,

Indianapolis, Ind.). Plaques exhibiting strong hybridization

ligated into the pGEM-T EASY vector (Promega, Madison,
Wis.) and subcloned into the pYeDP60 vector. The resulting

Were plaque puri?ed, auto-subcloned to their plasmid forms
according to the manufacturer’s recommendations (Strat
agene, La Jolla, Calif.), and then subjected to DNA sequenc

and elongating at 68° for 1.5 minutes. PCR products Were
35

constructs Were validated by a combination of PCR and DNA

sequencing.

ing as described above.

RNA Analysis
RNA gel blot analysis Was carried out using 10 pg aliquots

Yeast Expression Studies
40

of total RNA. RNA samples Were heat-denatured at 70° C. for

15 minutes in sample buffer (1>< MOPS, 50% formamide,
16% formaldehyde, 30% glycerol, and 3% ethidium bro
mide), and size fractionated on a 1 .2% agarose gel containing

1>< MOPS and 18.1% formaldehyde. Uniformity of sample
loading Was determined by visual inspection of the gel for

45

bidopsis Zhaliana (Pompon et al., Methods Enzymol. 272:51
64, 1996; Urban et al., J. Biol. Chem. 272:19176-19186,

nylon membrane (Bio-Rad Laboratories, Hercules, Calif.)
dations. Full-length cDNAs probes Were labeled With [32P]

1997), in the WAT1 1 line. Yeast Was groWn overnight in a 30°
50

dCTP (PRIME-IT Kit, Stratagene, La Jolla, Calif.) prior to

55

(Molecular Dynamics, model 445 SI).
Construction of Yeast Expression Vectors.
The coding regions of the P450 cDNAs Were cloned into
the pYeDP60 expression vector (Urban et al., J. Biol. Chem.

C. shaker in YPAD (1 g/l yeast extract; 1 g/l peptone; 20 g/l
glucose; 200 mg/l adenine) liquid media. Cultures Were har
vested at anA600 betWeen 0.5 and 1.5. Cells Were collected by
centrifugation at 2,500><g for 5 minutes at 4° C., and resus

hybridization. After hybridization, the membranes Were
Washed in 2><SSC/0.1% SDS once at room temperature fol

loWed by sequential Washes in 0.2><SSC/0.1% SDS at 42° C.
and 65° C. Hybridization Was detected With a Phosphoimager

(MAT a; ade 2-1; his 3-11; leu 2-3, -112; ura 3-1; canR; cyr”),
provided by Dr. P. Urban (Centre de Genetique Moléculaire,
CNRS, Gif- sur-Yvette, France). The endogenous NADPH
cytochrome P450 reductase (CPR1) locus has been replaced
WithATR1, a NADPH-cytochrome P450 reductase fromAra

rRNA bands. The RNAs Were then transferred to a Zeta Probe

and hybridized according to the manufacturer’s recommen

Veri?ed pYeDP60-P450 cDNA constructs Were introduced
into the yeast WAT1 1 line, a derivative of the W3 03-1B strain

pended in ice-cold, sterile dH2O. Cells Were pelleted again as
above and resuspended in 1 M sorbitol. Forty pl of yeast
suspension Was mixed With 0.5 to 1 pg plasmid DNA (in <5 pl
dH2O) in a pre-chilled 0.5 ml tube, and transferred to a chilled
cuvette With a 0.2 cm electrode gap. One pulse at 1.5 kV, 25

60

pF, and 200 Ohms Was applied by an Eppendorf Electropo
rator (model 2510).A mixture of 500 pl ofYPAD/1 M sorbitol

272: 19176-19186, 1990; Pompon et al., Methods Enzymol.
272:51-64, 1996). Appropriate BamHI, EcoRi, and SstI

Was immediately added to the electroporated cells. Cells Were
alloWed to recover at 30° C. for 1 hour, then spread onto SGI

restriction sites (underlined) Were introduced via PCR prim
ers containing these sequences either upstream of the trans
lation start site (ATG) or doWnstream of the stop codon (TAA
or TGA). The primers used to amplify the CYP71D20 cDNA

plates (1 g/l bactocasamino acids; 7 g/l yeast nitrogenbase; 20
g/l glucose; 20 mg/l tryptophan; and 20 g/l agar). Trans

Were

5'-GGGGGATCCATGCAATTCTTCAGCTTGGTT

65

formed colonies appeared after 3 to 6 days of incubation at
30° C. Recombinant plasmids Were con?rmed by PCR assays

performed directly on randomly selected yeast colonies.
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extracted With tWo volumes of ethyl acetate. The organic

For expression studies, one colony Was added to SGI media

(1 g/l bactocasamino acids; 7 g/l yeast nitrogen base; 20 g/l

extracts Were concentrated and evaluated by GC and GC-MS

glucose; and 20 mg/l tryptophan) and grown at 30° C. for
approximately 24 hours.An aliquot of this culture Was diluted
1:50 into 250 ml of YPGE (10 g/l bactopeptone; 10 g/l yeast

extract; 5 g/l glucose; and 3% ethanol by volume) and the

along With standards of 5-epi-aristolochene (Whitehead et al.,
Phytochemistry 28:775-779, 1989; Rising et al., J. Am.
Chem. Soc. 122: 1 861-1866, 2000), 1-deoxycapsidiol
(Whitehead et al., Phytochemistry 29:479-182, 1990), and

cells Were groWn until all glucose Was consumed. The

capsidiol (Whitehead et al., Phytochemistry 26:1367-1369,

absence of glucose Was determined by placing a 200 pl ali

1987; Milat et al., Phytochemistry 30:2171-2173, 1991). GC

quot of culture into a 1.5 ml tube, inserting a DIASTIX

analysis Was routinely performed With an HP5890 GC
equipped With a HeWlett-Packard HP-5 capillary column (30
m><0.25 mm, 0.25 um phase thickness) and FID as described

urinalysis reagent strip (Bayer, Elkhart, Ind.) for 30 seconds,
and observing colorimetric changes indicating glucose levels.
Induction Was initiated by the addition of 5 grams of galactose
(?nal concentration of 2%). The cultures Were maintained at
30° C. for an additional 16 hours before collecting the cells by

previously (Rising et al., J. Am. Chem. Soc. 122: 1861-1866,
2000). GC-MS analysis Was performed at the University of
Kentucky Mass Spectrometry Facility using a Varian 3400
gas chromatograph and a Finnigan INCOS 50 quadrupole

centrifugation at 7,000><g for 10 minutes. The pelleted cells
Were Washed With 100 ml of TES buffer (50 mM Tris-HCl pH,
7.5; 1 mM EDTA; 0.6 M sorbitol). The cells Were centrifuged

mass selective detector. The GC Was equipped With a J&W

DB-5 ms capillary column (15 m><0.25 mm, 0.25 pm phase
thickness) and run With He as the carrier gas (10 psi.). Split
less injections Were done at an injection port temperature of

as above, resuspended in 100 ml of TES-M (TES supple
mented With 10 mM 2-mercaptoethanol), and alloWed to
incubate at room temperature for 10 minutes. The yeast cells
Were centrifuged again at 7,000><g for 10 minutes, and the
pellet Was resuspended in 2.5 ml extraction buffer (1% bovine
serum albumin, fraction V; 2 mM 2-mercaptoethanol; 1 mM

phenylmethylsulfonyl ?uoride, all dissolved in TBS). Glass
beads (0.5 mm in diameter, Biospec Products, Inc., Bartles

20

FolloWing separation by the GC column, samples Were intro
duced directly into the electron impact ioniZation source.
Mass spectra Were acquired at 70 eV, scanning from 40-440
25

ville, Okla.) Were added until skimming the surface of the cell
shaking in a cold room for 10 min at 30 second intervals
separated by 30 second intervals on ice. Cell extracts Were
30

P450s, one may readily design P450-speci?c oligonucleotide

probes, including P450 degenerate oligonucleotide probes
35

40

45

and the mixture Was distributed betWeen tWo cuvettes. A

niques, for example, polymerase chain reaction (PCR) clon
Hybridization techniques and screening procedures are

50

of 91 mM_l.cm_l.

5-epi-aristolochene-1, 3-hydroxylase Assays
55

example, in Ausubel et al. (supra); Berger and Kimmel (su
pra); Chen et al., Arch. Biochem. Biophys. 324:255, 1995;
and Sambrook et al., Molecular Cloning: A Laboratory
Manual, Cold Spring Harbor Laboratory Press, NeW York. If
desired, a combination of different oligonucleotide probes
may be used for the screening of a recombinant DNA library.

The oligonucleotides may be detectably-labeled using meth
ods knoWn in the art and used to probe ?lter replicas from a
recombinant DNA library. Recombinant DNA libraries are

aristolochene or 1-deoxycapsidiol dissolved in hexane Was

added to the tube, and the organic solvent Was removed by
incubation of the open tube at 30° C. 5-epi-aristolochene and

1-deoxycapsidiol Were resuspended in 2 pl dimethyl sulfox

otides are useful for P450 gene isolation, either through their
use as probes capable of hybridiZing to a P450 complemen
tary sequence, or as primers for various ampli?cation tech

Well knoWn to those skilled in the art and are described, for

tional P450 Was estimated based on an absorbance coef?cient

5-epi-aristolochene-1, 3-hydroxylase assays Were per
formed in 0.5 ml polyethylene tubes in 100 pl volumes. 5-epi

designing and preparing such probes are provided, for
example, in Ausubel et al., 2000, Current Protocols in
Molecular Biology, Wiley Interscience, NeW York, and
Berger and Kimmel, Guide to Molecular Cloning Tech
niques, 1987, Academic Press, NeW York. These oligonucle

ing strategies.

baseline Was recorded betWeen 400 and 500 nm on a Perkin

difference spectrum recorded again. The amount of func

(i.e., a mixture of all possible coding sequences for a given
amino acid sequence). These oligonucleotides may be based
upon the sequence of either DNA strand and any appropriate
portion of the P450 nucleotide sequence. General methods for

at —80° C. until further assayed.

Elmer Lambda 18 UV/visible spectrophotometer. CO Was
then bubbled into the sample cuvette for 1 minute, and the

Using the standard molecular techniques described herein,
the isolation of additional cytochrome P450 coding
sequences is readily accomplished. For example, using all or
a portion of the amino acid sequence of any of the disclosed

TEG-M buffer (50 mM Tris-HCl, pH 7.5; 1 mM EDTA; 20%
glycerol; and 1.5 mM 2-mercaptoethanol) and stored froZen
CO Difference Spectra
Fe2+.CO vs. Fe2+ difference spectroscopy (Omura and
Sato, J. Biol. Chem. 239:2370-2373, 1964) Was performed
using 0.4 ml of microsomes suspended in 1.6 ml of 50 mM
Tris-HCl, pH 7.5; 1 mM EDTA; and 20% glycero. A small
amount of the reducing agent, sodium dithionite, Was added,

Da in 1 second.

Production of Cytochrome P450s

suspension. Cell Walls Were disrupted manually by hand
transferred to a 50 ml centrifuge tube, the glass beads Were
Washed three times With 5 ml of extraction buffer, and the
Washes Were pooled With the original cell extracts.
Microsomes Were prepared by differential centrifugation at
10,000 g for 10 minutes at 4° C. to remove cellular debris,
folloWed by centrifugation at 100,000><g for 70 minutes at 4°
C., and microsomal pellets Were resuspended in 1.5 ml

280° C. The column temperature Was maintained at 40° C. for
1 minute and then increased to 280° C. at 10° C. per minute.

60

prepared according to methods Well knoWn in the art, for
example, as described inAusubel et al. (supra), or they may be

ide before adding the reaction mixture. Reactions Were car

obtained from commercial sources.

ried out in 100 mM Tris-HCl, pH 7.5, to Which microsomal

As discussed above, P450 oligonucleotides may also be
used as primers in a polymerase chain reaction (PCR) ampli
?cation cloning strategy. PCR methods are Well knoWn in the
art and are described, for example, in PCR Technology,

protein Was added to a ?nal concentration of 1 mg/ml. Reac
tions Were initiated by the addition of 2 mM NADPH. The

?nal concentration of 5-epi-aristolochene and 1-deoxycap
sidiol in these assays varied from 20 to 50 uM. After incuba
tions for variable lengths of time at 30° C., the reactions Were

65

Erlich, ed., Stockton Press, London, 1989; PCR Protocols: A
Guide to Methods and Applications, Innis et al., eds., Aca
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For prokaryotic expression, DNA encoding a P450

demic Press, Inc., NeWYork, 1990; andAusubel et al. (supra).
Primers are optionally designed to allow cloning of the ampli
?ed product into a suitable vector, for example, by including

polypeptide is carried on a vector operably linked to control

signals capable of effecting expression in the prokaryotic

appropriate restriction sites at the 5' and 3' ends of the ampli
?ed fragment (as described herein). If desired, a P450 gene
may be isolated using the PCR “RACE” technique, or Rapid
Ampli?cation of cDNA Ends (see, e.g., Innis et al. (supra)).
By this method, oligonucleotide primers based on a P450

host. If desired, the coding sequence may contain, at its 5' end,
a sequence encoding any of the knoWn signal sequences

sequence are oriented in the 3' and 5' directions and are used

most frequently used are various strains of E. coli; hoWever,

capable of effecting secretion of the expressed protein into the
periplasmic space of the host cell, thereby facilitating recov

ery of the protein and subsequent puri?cation. Prokaryotes

to generate overlapping PCR fragments. These overlapping

other microbial strains may also be used. Plasmid vectors are

3'- and 5'-end RACE products are combined to produce an
intact full-length cDNA. This method is described in Innis et

used Which contain replication origins, selectable markers,
and control sequences derived from a species compatible With
the microbial host. Examples of such vectors are found in
PouWels et al. (supra) or Ausubel et al. (supra). Commonly

al. (supra); and Frohman et al., Proc. Natl. Acad. Sci. USA

8518998, (1988).
P450 s are provided in Maughan et al (Arch. Biochem. Bio

used prokaryotic control sequences (also referred to as “regu
latory elements”) are de?ned herein to include promoters for

phys. 3411104-111, 1997) and Clark et al. (Plant Mol. Biol.

transcription initiation, optionally With an operator, along

331875-885, 1997).

With ribosome binding site sequences. Promoters commonly
used to direct protein expression include the beta-lactamase

Additional methods for identifying sequences encoding

Useful P450 sequences may be isolated from any appro

priate organism. Con?rmation of a sequence’s relatedness to
a P450 polypeptide disclosed herein may be accomplished by
a variety of conventional methods, for example, by compar

20

moter systems, as Well as the lambda-derived P.sub.L pro

ing the sequence With a knoWn p450 sequence found in a

database. In addition, the activity of any P450 may be evalu
ated according to any of the techniques described herein.

25

P450 Polypeptide Expression
P450 polypeptides may be produced by transformation of
a suitable host cell With all or part of a P450 DNA (for
example, any one of the P450 cDNAs described herein) in a

(penicillinase), the lactose (lac), the tryptophan (Trp) (Goed
del et al., Nucl. Acids Res. 814057 (1980)), and the tac pro

moter and N-gene ribosome binding site (Simatake et al.,
Nature 2921128 (1981)).
One particular bacterial expression system for P450 pro
duction is the E. coli pET expression system (Novagen).
According to this expression system, DNA encoding a P450
is inserted into a pET vector in an orientation designed to

alloW expression. Since the P450 gene is under the control of

neered for increasing the expression of a P450 polypeptide in

the T7 regulatory signals, P450 expression is dependent on
inducing the expression of T7 RNA polymerase in the host
cell. This is typically achieved using host strains Which

vivo.
Those skilled in the ?eld of molecular biology Will appre
ciate that any of a Wide variety of expression systems may be

Once produced, recombinant P450 is then isolated according
to standard methods knoWn in the art, for example, those

30

suitable expression vehicle or With a plasmid construct engi

express T7 RNA polymerase in response to IPTG induction.
35

used to provide the recombinant protein. The precise host cell

described herein.

used is not critical to the invention. The P450 protein may be

Another bacterial expression system for P450 production
is the pGEX expression system (Pharmacia). This system

produced in a prokaryotic host, for example, E. coli TB 1, or in

a eukaryotic host, for example, Saccharomyces cerevisiae,
insect cells, mammalian cells (for example, COS 1 or NIH
3T3 cells), or any of a number of plant cells including, With
out limitation, algae, tree species, ornamental species, tem

employs a GST gene fusion system that is designed for high
40

With rapid puri?cation and recovery of the functional gene
product. The P450 of interest is fused to the carboxyl terminus
of the glutathione S-transferase protein from Schislosoma

perate fruit species, tropical fruit species, vegetable species,
legume species, monocots, dicots, or in any plant of commer
cial or agricultural signi?cance. Particular examples of suit
able plant hosts include, but are not limited to, Conifers,

45

tuce, Sun?ower, Oilseed rape, Flax, Cotton, Sugarbeet, Cel
50

let, Onion, Barley, Orchard grass, Oat, Rye, Tobacco, and
Wheat.
Such cells are available from a Wide range of sources

including: the American Type Culture Collection (Rockland,

japonicum and is readily puri?ed from bacterial lysates by
al?nity chromatography using Glutathione Sepharose 4B.
Fusion proteins can be recovered under mild conditions by

Petunia, Tomato, Potato, Tobacco, Grape, Arabidopsis, Let

ery, Soybean, Alfalfa, Medicago, Lotus, Vigna, Cucumber,
Carrot, Eggplant, Cauli?ower, Horseradish, Morning Glory,
Poplar, Walnut, Apple, Asparagus, Grape, Rice, Maize, Mil

level expression of a gene or gene fragment as a fusion protein
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elution With glutathione. Cleavage of the glutathione S-trans
ferase domain from the fusion protein is facilitated by the
presence of recognition sites for site-speci?c proteases
upstream of this domain. For example, proteins expressed in
pGEX-2T plasmids may be cleaved With thrombin; those
expressed in pGEX-3X may be cleaved With factor Xa.
Other prokaryotic systems useful for expressing eukary
otic P450s are described by Cooper (Mutat. Res. 454145-52,
2000) and Dong et al. (Arch. Biochem. Biophys. 3271254

Md.); or from any of a number seed companies, for example,

259, 1996). In addition, strategies for enhancing the prokary

W. Atlee Burpee Seed Co. (Warminster, Pa.), Park Seed Co.

otic expression of a cytochrome P450 in combination With
cytochrome reductase are described in Porter et al. (Drug.

(Greenwood, SC), Johnny Seed Co. (Albion, Me.), or

Northrup King Seeds (Harstville, S.C.). Descriptions and
sources ofuseful host cells are also found in Vasil I. K., Cell

Metab. Rev. 311159-174, 1999).
60

Culture and Somatic Cell Genetics of Plants, Vol I, II, III
Laboratory Procedures and Their Applications Academic
Press, NeW York, 1984; Dixon, R. A., Plant Cell CultureiA

Practical Approach, IRL Press, Oxford University, 1985;
Green et al., Plant Tissue and Cell Culture, Academic Press,
NeW York, 1987; and Gasser and Fraley, Science 24411293,

(1989).
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For eukaryotic expression, the method of transformation or
transfection and the choice of vehicle for expression of the
P450 Will depend on the ho st system selected. Transformation
and transfection methods of numerous organisms, for

example, the baker’s yeast Saccharomyces cerevisiae, are
described, e.g., in Ausubel et al. (supra); Weissbach and
Weissbach, Methods for Plant Molecular Biology, Academic
Press, 1989; Gelvin et al., Plant Molecular Biology Manual,

